← Banking With Billy News

🚨 MARKET UPDATE: Nektar Therapeutics (NKTR) plummets 11% as jury continues deliberations in its patent dispute with Eli Lilly (LLY) over the Rezpeg drug. Jury

Instant Stock Alerts • 2026-09-22 21:01 UTC • By Billy Odell Tucker-Robinson
🚨 MARKET UPDATE: Nektar Therapeutics (NKTR) plummets 11% as jury continues deliberations in its patent dispute with Eli Lilly (LLY) over the Rezpeg drug. Jury
🚨 MARKET UPDATE: Nektar Therapeutics (NKTR) plummets 11% as jury continues deliberations in its patent dispute with Eli Lilly (LLY) over the Rezpeg drug. Jury has been deliberating since Friday. #Biotech #Patents
Share this article
𝕏 X / Twitter Facebook LinkedIn WhatsApp
📚 More from Billy’s World
📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly